| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $326.5M | -4.9% |
| Cost of Revenue | $284.8M | -33.2% |
| Gross Profit | $41.7M | +150.4% |
| R&D Expense | $28.1M | -28.8% |
| SG&A Expense | $169.7M | -23.0% |
| Operating Income | -$156.1M | +54.3% |
| Pre-tax Income | -$160.2M | +52.1% |
| Income Tax | -$26K | -620.0% |
| Net Income | -$160.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $131.9M | -30.8% |
| Accounts Receivable | $26.9M | -15.3% |
| Inventory | $113.4M | -13.0% |
| Current Assets | $286.5M | -23.2% |
| Total Assets | $678.1M | -12.4% |
| Current Liabilities | $61.5M | -17.4% |
| Long-term Debt | $1.14B | +0.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.8M | +8.4% |
| Capital Expenditures | $11.0M | +4.3% |
| Investing Cash Flow | -$6.2M | +34.3% |
| Financing Cash Flow | $45.8M | +8423.1% |
| Free Cash Flow | -$109.8M | +7.2% |
| +52.6% |
| EPS (Basic) | -$2.43 | +53.8% |
| EPS (Diluted) | -$2.43 | +53.8% |
| Stockholders' Equity |
| -$601.2M |
| -17.1% |